References
- Tomioka S, Kobayashi T, Takasaka T. Intractable otitis media in patients with bronchial asthma (eosinophilic otitis media). In: Sanna M, editor. Cholesteatoma and mastoid surgery. Rome: CIC Edizioni Internazionali; 1997. p. 851–3.
- Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx 2011;38:456–61.
- Liu Y, Zhang Z. The eosinophilic otitis media’s research progress. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2015;29:1577–80. (In Chinese).
- de Jong MA, Smithuis LO, Stokross RJ. [Eosinophilic otitis media]. Ned Tijdschr Geneeskd 2014;158:A8044. (In Dutch).
- Azadarmaki R, Westra W, Prasad S. Eosinophilic mucin otomastoiditis and otopolyposis: a progressive form of eosinophilic otitis media. Ann Otol Rhinol Laryngol 2015;124:752–6.
- Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma. Otol Neurotol 2008;29:949–52.
- Nakagawa T, Matsubara A, Shiratsuchi H, Kakazu Y, Nakashima T, Koike K. Intractable otitis media with eosinophils: importance of diagnosis and validity of treatment for hearing preservation. Orl J Otorhinolaryngol Relat Spec 2006;68:118–22.
- Jose PJ, Griffiths-Jonson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881–7.
- Bartels J, Maune S, Meyer JE, Kulke R, Schluter C, Rowert J, et al. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression. Rhinology 1997;35:171–4.
- Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997;99:S763–72.
- Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S, Pawankar R, et al. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol 2003;123:383–7.
- Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy 2005;35:1370–6.
- Nishizawa H, Matsubara A, Nakagawa T, Ohta N, Izuhara K, Shirasaki T, et al. The role of periostin in eosinophilic otitis media. Acta Otolaryngol 2012;132:838–44.
- Matsubara A, Nishizawa H, Kurose A, Nakagawa T, Takahata J, Sasaki A. An experimental study of inner ear injury in an animal model of eosinophilic otitis media. Acta Otolaryngol 2014;134:227–32.
- Kanazawa H, Yoshida N, Shinnabe A, Iino Y. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media. Ann Allergy Asthma Immunol 2014;113:88–92.
- Nonaka M, Pawankar R, Saji F, Yagi T. Eotaxin synthesis by nasal polyp fibroblasts. Acta Otolaryngol 1999;119:816–20.
- Yao T, Kojima Y, Koyanagi A, Yokoi H, Saito T, Kawano K, et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope 2009;119:1053–9.
- Takumida M. Mechanism and treatment of the inner ear disorders in otitis media. Otology Japan 2004;14:36–8.